Grants & Projects per year
Personal profile
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Grants & Projects
- 10 Finished
-
Advanced testing of a hexavalent adjuvanted influenza vaccine platform for dose sparing, multiplexing, and rapid deployment
Davidson, B. (PI) & Lovell, J. (CoI)
National Institute of Allergy & Infectious Disease
06/1/24 → 05/31/26
Project: Research
-
SPIR: Multivalent QS-18 protein nanoparticles for a broadly protective influenza virus vaccine
Davidson, B. (PI) & Lovell, J. (CoI)
National Institute of Allergy & Infectious Disease
09/30/23 → 10/31/25
Project: Research
-
Immunotherapy for acute lung injury secondary to influenza
Knight, P. (PI), Davidson, B. (CoI), Prasad, P. (CoI) & Sullivan, J. (CoI)
National Heart Lung and Blood Institute
04/1/20 → 03/31/25
Project: Research
-
STTR: An adjuvanted influenza vaccine platform for dose sparing, multiplexing, and rapid deployment
Davidson, B. (PI), Knight, P. (CoI) & Lovell, J. (CoI)
National Institute of Allergy & Infectious Disease
02/10/20 → 04/30/22
Project: Research
-
UB Center for Advanced Technology in Big Data and Health Sciences
Nowak, N. (PI), Dunbar, J. (CoPI), Arany, P. (CoI), Bankert, R. (CoI), Buck, M. (CoI), Davidson, B. (CoI), Ehrensberger, M. (CoI), Gao, J. (CoI), Kolega, J. (CoI), Lovell, J. (CoI), Murphy, T. (CoI), Qu, J. (CoI), Rasmusson, R. (CoI), Sajjad, M. (CoI), Titus, A. (CoI), Wang, J. (CoI), Weil, B. (CoI), Wu, Y. (CoI) & Yao, R. (CoI)
NYS Department of Economic Development
07/1/19 → 06/30/20
Project: Research
-
Preparing Adjuvanted Nanoliposomes for Applications Toward Recombinant Influenza Vaccine Development
Sia, Z. R., Huang, W. C., Willadsen, M., Kutscher, H. L., Lovell, J. F. & Davidson, B. A., Apr 5 2026, In: Bio-protocol. 16, 7, e5662.Research output: Contribution to journal › Article › peer-review
Open Access -
Femtosecond laser-ablative aqueous synthesis of multi-drug antiviral nanoparticles
Schmitt, R. R., Davidson, B. A., He, D., He, G. S., Bulmahn, J. C., Sambhara, S., Knight, P. R. & Prasad, P. N., 2025, In: Nanomedicine. 20, 7, p. 691-699 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Highly pathogenic avian influenza H5N1 clade 2.3.4.4b hemagglutinin and/or neuraminidase elicit immunity in a recombinant nanoparticle vaccine
Li, Q., Vendramelli, R., Truong, T., Jeevan, T., Black, M., Luo, Y., Song, Y., Huang, W. C., Zhou, S., Berhane, Y., Davidson, B. A., Webby, R. J., Kobasa, D. & Lovell, J., Jun 24 2025, In: Cell Biomaterials. 1, 5, 100070.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Tuning the tropism and infectivity of SARS-CoV-2 virus-like particles for mRNA delivery
Yang, Q., Davidson, B. A., Pajic, P., Chen, X., Gokcumen, O., Gao, M. & Neelamegham, S., Mar 24 2025, In: Nucleic Acids Research. 53, 5, gkaf133.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Adjuvanted nanoliposomes displaying six hemagglutinins and neuraminidases as an influenza virus vaccine
Sia, Z. R., Roy, J., Huang, W. C., Song, Y., Zhou, S., Luo, Y., Li, Q., Arpin, D., Kutscher, H. L., Ortega, J., Davidson, B. A. & Lovell, J. F., Mar 19 2024, In: Cell Reports Medicine. 5, 3, 101433.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations